Analyst consensus rating
Globe Life Analyst Rating: Buy
Direct answer
Globe Life's consensus rating is Buy.
11 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $193.18.
Forecast evidence checked October 17, 2026.
Get free Globe Life email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $168.77
- Average price target
- $193.18
- High price target
- $225.00
- Low price target
- $166.00
- Low target gap
- -1.6%
- Target upside
- +14.5%
- High target gap
- +33.3%
- Target range width
- 35%
- Consensus rating
- Buy
- Analysts
- 11
- Evidence date
- October 17, 2026
- Valid through
- October 24, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Globe Life?
Globe Life has a verified Buy consensus. The same dataset has an average price target of $193.18.
How far are Globe Life's low and high targets from the recorded price?
The low target implies -1.6%, while the high target implies +33.3%.
How many analysts are included in Globe Life's consensus?
The verified consensus includes 11 analysts.
How is Globe Life's target upside or downside calculated?
The average target of $193.18 is divided by the recorded price of $168.77, then one is subtracted to produce +14.5%. This does not guarantee a future return.
When was Globe Life's analyst forecast verified?
The data was verified on 2026-10-17. The dataset is valid through 2026-10-24.